iFocus Health
AI-powered objective measures for ADHD and brain health, driving faster decisions, better outcomes,
Startup Pre-Funding Health Tech & Life Sciences United States Est. 2021
Total Raised
Undisclosed
Pre-Funding
Last Round
Undisclosed
Team
3
1-10 employees
Confidence
90/100
News
1
articles
About
iFocus Health isn’t following the herd. We’re not simply adding technology to traditional methods—we recognize that for mental health care to truly scale, clinicians need an objective, real-world measure that’s easy for them and their patients. Our solution provides an objective tool for screening for ADHD and tracking patient progress. With a scalable, AI-powered platform using eye-tracking technology, iFocus delivers clear, actionable insights that improve clinical efficiency, streamline follow-ups, and open new revenue streams for providers. By offering precise, real-world metrics, iFocus is transforming ADHD care, enhancing patient outcomes, and reducing biases. This is a unique opportunity to drive meaningful impact in healthcare while delivering substantial returns for investors. Key strengths and achievements: Patent-pending technology validated by a peer-reviewed study, with the potential to expand beyond ADHD to address other mental health conditions Over 700 users referred by leading clinicians from prominent healthcare organizations such as Sutter Health, Kaiser Permanente, and One Medical Subscription-based model offering clinicians a significant opportunity to increase their income while contributing to cost savings and improved efficiency.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical MonitorsDigital HealthcarePatient Remote Monitoring
Core Technology
Artificial IntelligenceMachine LearningImage RecognitionPlatforms & InterfacesSoftware
Target Customer
Healthcare & Life SciencesHealthcareInsurance CompaniesPatientsProviders
Business Model
B2B
Tags
adhdmachine-learningmental-healtheye-trackingmedical-devices
News (1)
Feb 26, 2024 · www.psypost.org
Growth-Positive
Eye-tracking assessments could be the future of ADHD treatment evaluation
CustomersPartners
Details
Product Stage
Released
Employees
1-10
Exact Count
5
Founded
2021
Locations
Ness Ziona, Israel
San Jose, CA, USA
Links
Website
LinkedIn
Facebook
Admin
Last Update
Mar 20, 2025
Verified by
Yanina Wainscheinker
Claimed
Yes
Missing
funding rounds, markets, not claimed
Team (3)
Adi Diner
CEO
Founder
Ravid Lazinsky
CPO
Founder
Einat Sitbon
CTO
Founder
Internal
Created by
Adi Diner (adi@ifocustest.com)
Created
2023-03-28T00:00:00.000Z
Last editor
Adi Diner (adi@ifocustest.com)